Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Cash from Operations (Quarterly): -6.717M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.717M |
| December 31, 2023 | -5.407M |
| September 30, 2023 | -7.551M |
| June 30, 2023 | -5.126M |
| March 31, 2023 | -6.017M |
| December 31, 2022 | -7.256M |
| September 30, 2022 | -7.577M |
| June 30, 2022 | -8.001M |
| March 31, 2022 | -4.805M |
| December 31, 2021 | -4.258M |
| September 30, 2021 | -4.288M |
| June 30, 2021 | -6.781M |
| March 31, 2021 | -3.624M |
| December 31, 2020 | -3.124M |
| September 30, 2020 | -5.372M |
| June 30, 2020 | -4.933M |
| March 31, 2020 | -4.342M |
| Date | Value |
|---|---|
| December 31, 2019 | -4.677M |
| September 30, 2019 | -3.327M |
| June 30, 2019 | -5.347M |
| March 31, 2019 | -3.847M |
| December 31, 2018 | -3.11M |
| September 30, 2018 | -2.819M |
| June 30, 2018 | -3.467M |
| March 31, 2018 | -2.807M |
| December 31, 2017 | -2.39M |
| September 30, 2017 | -1.611M |
| June 30, 2017 | -1.932M |
| March 31, 2017 | -1.391M |
| December 31, 2016 | -1.169M |
| September 30, 2016 | -0.951M |
| June 30, 2016 | -1.355M |
| March 31, 2016 | -0.29M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.001M
Minimum
Jun 2022
-3.124M
Maximum
Dec 2020
-5.426M
Average
-5.236M
Median
Cash from Operations (Quarterly) Benchmarks
| Merck & Co Inc | 3.09B |
| Lixte Biotechnology Holdings Inc | -0.7892M |
| Moderna Inc | -989.00M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -24.80M |
| Free Cash Flow Per Share (Quarterly) | -2.724 |
| Free Cash Flow Yield | -232.2% |